Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Recursion Pharmaceuticals Inc (RXRX) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Kohl's insider sells 18,352 shares amid mixed market views on stock's future.

Kohl's Chief Legal and Corporate Affairs Officer Jennifer J. Kent sold 18,352 shares for $403,744 on October 15, 2026, reducing her stake to 211,512 shares. Market opinions on Kohl's stock are divided, with some analysts expecting a decline while oth...

Market News
1 hour ago
Andrew Wynn
Neutral
Kohl's insider sells 18,352 shares amid mixed market views on stock's future.

Copper explorers in British Columbia use electrical surveys to identify promising drill targets amid rising copper prices.

Copper exploration in British Columbia is increasingly relying on induced polarization (IP) geophysical surveys, which measure electrical chargeability and resistivity in rocks to identify sulphide mineralization associated with copper deposits. Gold...

Market News
2 hours ago
Equity Insider
Bullish
news icon
Copper explorers in British Columbia use electrical surveys to identify promising drill targets amid rising copper prices.

S&P 500 rises 30.6% in first 20 months of Trump's second term, nearing first term gains.

The S&P 500 index has increased by 30.6% during the first 20 months of Donald Trump's second presidential term, slightly surpassing the 28.5% gain recorded in the same period of his first term. This comparison is significant for investors as it provi...

Market News
2 hours ago
James Brumley
Neutral
S&P 500 rises 30.6% in first 20 months of Trump's second term, nearing first term gains.

Over 200 companies advance next-gen obesity drugs with new therapies and clinical trials surging globally

The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...

Market News
4 hours ago
Delveinsight
Bullish
news icon
Over 200 companies advance next-gen obesity drugs with new therapies and clinical trials surging globally

Alice, Inflection AI, and AI21 show NVIDIA Nemotron models can be trained for advanced AI safety and security.

Alice collaborated with Inflection AI and AI21 to demonstrate that NVIDIA Nemotron open models can be post-trained using real-world adversarial data to enhance AI safety and security without losing capability. Inflection AI improved conversational AI...

Market News
4 hours ago
Not Specified
Bullish
news icon
Alice, Inflection AI, and AI21 show NVIDIA Nemotron models can be trained for advanced AI safety and security.

Natera stock surges 76% after long-term breakout, eyes next rally above $437.41

Natera, Inc. (NTRA) has gained over 76% since breaking out of a long-term base in November 2024, reaching a new high of $437.41 last week. After a brief pullback to key support near its 20-day moving average, the stock has consolidated while maintain...

Technical Signals
4 hours ago
FXEmpire
Bullish
news icon
Natera stock surges 76% after long-term breakout, eyes next rally above $437.41

Anthropic partners with nonprofits to embed independent AI safety evaluators.

Anthropic announced partnerships with nonprofits METR and SecureBio, and discussions with Hugging Face, to embed independent evaluators within the company. This move follows CEO Dario Amodei's proposal to slow AI model development and ensure safety t...

Market News
4 hours ago
CNBC
Bullish
news icon
Anthropic partners with nonprofits to embed independent AI safety evaluators.

Hyster-Yale names Matthew J. Cornell as new CFO starting November 1, 2026

Hyster-Yale, a global lift truck manufacturer, announced Matthew J. Cornell as its new Senior Vice President and Chief Financial Officer effective November 1, 2026. Cornell brings over 20 years of financial and operational experience from Stanley Bla...

Market News
4 hours ago
PRNewsWire
Neutral
Hyster-Yale names Matthew J. Cornell as new CFO starting November 1, 2026

Porsche unveils Mission S concept, signaling a new flagship model above the 911.

Porsche revealed the Mission S, a midengine concept car that previews the brand's new design direction and a planned 'super sports car platform' positioned above the iconic 911. This launch aligns with Porsche's recent strategy focusing on higher-end...

Market News
4 hours ago
CNBC
Bullish
news icon
Porsche unveils Mission S concept, signaling a new flagship model above the 911.

FACTS launches Compass platform to help manage Federal Scholarship Tax Credit for schools.

FACTS, a Nelnet company, introduced FACTS Compass, a new platform to assist Scholarship Granting Organizations (SGOs) in administering the Federal Scholarship Tax Credit (FSTC). This platform aims to streamline scholarship management for both public ...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
FACTS launches Compass platform to help manage Federal Scholarship Tax Credit for schools.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $2.02B
  • Volume
    18,610,436
  • Sector
    Health
  • 52W High
    $6.79
  • 52W Low
    $2.84
  • Typical Hold Time
    21 Days
  • Enterprise Value
    $1.54B
  • Div Yield
    -
  • Trading Activity
    41% Sell | 59% Buy
$4.18
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Track Recursion Pharmaceuticals Inc (RXRX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Buy and sell Recursion Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!